Together these findings prompted us to design an experimental model in vitro that would allow us to evaluate how neutrophil-derived products themselves and in combination with exogenously added native AAT or its C-36 peptide influence lung cancer HCC cell growth, invasion and metastatic properties. This evidence concerns the gene SERPINA1 and hepatocellular carcinoma.